Alembic Pharmaceuticals informs about USFDA product approval

09 May 2024 Evaluate
Alembic Pharmaceuticals has informed that the Company has received various US Food & Drug Administration (USFDA) (Tentative or Final) Product Approvals. The summary statement giving brief of all product approvals received from 1st April, 2024 till 8th May, 2024 is enclosed for information and records. Alembic has a cumulative total of 201 ANDA approvals (173 final approvals and 28 tentative approvals) from USFDA.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

1040.05 1.85 (0.18%)
22-Nov-2024 11:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1770.85
Dr. Reddys Lab 1202.00
Cipla 1478.10
Lupin 2051.15
Zydus Lifesciences 941.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.